Sandoz to acquire GSK’s cephalosporin antibiotics business for $500m
Sandoz, a division of the Swiss pharmaceutical giant Novartis, has finalized a deal to acquire the cephalosporin antibiotics business from GSK (GlaxoSmithKline) for up to ... Read More
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen ... Read More